Come up with a name for your new list and we'll add to it:
Vivid Genomics raised a round of funding on September 14, 2018. Investors include
Ad Astra Ventures.
Vivid Genomics is a diagnostic company developing non-invasive ways to identify neuro-degenerative disease pathologies, drug response, progression rate and tools to facilitate enrollment in clinical t…